Anthony Kirck
Comptroller/Controller/Auditor at OPTINOSE, INC.
Net worth: 130 309 $ as of 2024-04-29
Profile
Anthony J.
Kirck's current job is Chief Accounting Officer, VP-Finance & Controller at OptiNose, Inc. His former jobs include Executive Director-Financial Planning & Analysis at Strongbridge Biopharma Plc from 2017 to 2020, and Controller at Verrica Pharmaceuticals, Inc. from 2020 to 2021.
He completed his undergraduate degree at Albright College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OPTINOSE, INC.
0.13% | 2024-03-17 | 143,988 ( 0.13% ) | 130 309 $ | 2024-04-29 |
Anthony Kirck active positions
| Companies | Position | Start |
|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 2021-10-31 |
Former positions of Anthony Kirck
| Companies | Position | End |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 2021-10-31 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 2020-01-31 |
Training of Anthony Kirck
| Albright College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Stock Market
- Insiders
- Anthony Kirck
